Vitamin D in Autoimmune and Infectious Diseases
A special issue of Life (ISSN 2075-1729). This special issue belongs to the section "Physiology and Pathology".
Deadline for manuscript submissions: closed (31 March 2025) | Viewed by 1631
Special Issue Editors
Interests: rheumatoid arthritis; tumor necrosis factor; fatty acids; treatment; systemic lupus erythematosus
Special Issues, Collections and Topics in MDPI journals
Interests: breast cancer; neuroendocrinology; melatonin; thyroid cancer; vitamin D; autoimmune diseases
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Vitamin D is a hormone with multiple actions and potent immunomodulatory properties, as it may enhance the innate immune response and may modulate the adaptive immune response. Vitamin D deficiency has been observed in various autoimmune diseases, such as rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis, inflammatory bowel disease, and systemic sclerosis. Vitamin D may be a useful addition in the therapeutic management of multiple sclerosis as it may modulate the autoimmune process involved in the pathogenesis of the disease. Vitamin D administration may also be useful in the management of systemic lupus erythematosus. Vitamin D may enhance the innate immune response and may be helpful in the fight against infectious diseases. Vitamin D deficiency has been related to the severity of SARS-CoV-2 infection, and its administration may be a useful addition in the armamentarium against this disease.
In this Special Issue, all articles related to vitamin D, its immunomodulatory properties, and its relationship with autoimmune and infectious diseases are welcome.
Dr. Panagiotis Athanassiou
Dr. Ifigenia Kostoglou-Athanassiou
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- vitamin D
- autoimmunity
- rheumatoid arthritis
- systemic lupus erythematosus
- systemic sclerosis
- infectious agents
- COVID-19
- SARS-CoV-2
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
